Roche tries hostile takeover bid for Genentech

Swiss drugmaker Roche, frustrated by stalled negotiations to purchase Bay Area biotech giant Genentech Inc., announced a hostile $42.1 billion takeover bid Friday that would net investors less than the $89 per share offer that Genentech rejected in

Leave a Reply